The Latest Cardiac and Vascular News
MyoVista® hsECG™ Utilizes Wavelet Technology to Detect Cardiac Diastolic Dysfunction SOUTHLAKE, Texas, Oct. 19, 2017 /PRNewswire-USNewswire/ — HeartSciences announced today that the company will launch its MyoVista® high sensitivity electrocardiograph (hsECG™) Testing Device in Canada at the Canadian Cardiovascular Congress (CCC) in Vancouver on October 21-24. The MyoVista hsECG is now available in Canada, where it received Health Canada Medical […]
NEW YORK, Oct. 4, 2017 /PRNewswire/ — Peerbridge Health Inc., a Health IT company, announced today that its first product, the Peerbridge Cor™ System — a wireless electrocardiogram (ECG) monitor — has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The patented Peerbridge Cor has the smallest on-body footprint of any […]
PARIS & SAN FRANCISCO–(BUSINESS WIRE)–Cardiologs Technologies announced today that it has raised $6.4 million in a Series A financing with a syndicate of life science and technology investors (Idinvest, ISAI, Kurma Partners, Partech Ventures) and with continued support and participation from current investor Bpifrance seed fund (F3A). This round brings total […]
Robustly Positive Results of SPAIN Study Published in Journal of American College of Cardiology BERLIN, Germany, October 4, 2017 – BIOTRONIK’s exclusive rate responsive technology, Closed Loop Stimulation (CLS) has shown to reduce fainting in pacemaker patients with vasovagal syncope up to sevenfold. Results from the SPAIN study, the first […]
MARLBOROUGH, Mass., Oct. 2, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Apama Medical Inc., a privately-held company that is developing the Apama Radiofrequency (RF) Balloon Catheter System for the treatment of atrial fibrillation (AF). The transaction consists of $175 million in cash up-front and a maximum […]
ANAHEIM, Calif.–(BUSINESS WIRE)–ClearFlow Inc., a medical device company based in Anaheim, California, has announced the publication of significantly positive results in a study evaluating the company’s PleuraFlow® Active Clearance Technology® System. Data from a peer-reviewed clinical study indicating a marked reduction in Postoperative Atrial Fibrillation (POAF) among patients with active clearance of chest […]
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) and MicroPort Scientific Corporation (HK:00853) (“MicroPort”), today announced that the companies’ Shanghai-based joint venture MicroPort Sorin Cardiac Rhythm Management Co. Ltd. (“MSC” or the “joint venture”) obtained approval for its family of RegaTM pacemakers from the China Food and Drug Administration. Not only are Rega pacemakers […]
MARLBOROUGH, Mass., Sept. 27, 2017 /PRNewswire/ — CardioFocus, Inc. today announced the European CE Mark approval of the HeartLight Excalibur Balloon, a next-generation technology designed for the treatment of atrial fibrillation (AF). The Excalibur Balloon leverages the proven universal balloon design of the company’s FDA-approved HeartLight® Endoscopic Ablation System and introduces an advanced feature set that optimizes the speed […]
MARLBOROUGH, Mass., Sept. 25, 2017 /PRNewswire/ — Boston Scientific (NYSE: BSX) has launched the Resonate family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems featuring the HeartLogic Heart Failure Diagnostic to help physicians improve heart failure (HF) management. The new devices, which are approved by the U.S. Food […]
ABBOTT PARK, Ill., Sept. 22, 2017 /PRNewswire/ — Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for one of Abbott’s most widely-used implantable cardioverter defibrillators (ICD) and associated high voltage leads. The approval of MR-conditional labeling for the Ellipse ICD with the Tendril MRI […]
